BAJAJHCARE - Bajaj Healthcare Limited Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

BAJAJHCARE

62/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹311.15-0.55(-0.18%)

Market Closed as of Apr 2, 2026, 15:30 IST

Select time range

Pros

Technicals: Bullish SharesGuru indicator.

Profitability: Recent profitability of 8% is a good sign.

Balance Sheet: Strong Balance Sheet.

Cons

Size: It is a small market cap company and can be volatile.

Smart Money: Smart money is losing interest in the stock.

Momentum: Stock is suffering a negative price momentum. Stock is down -12% in last 30 days.

Past Returns: Underperforming stock! In past three years, the stock has provided 0.4% return compared to 9.3% by NIFTY 50.

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

BAJAJHCARE - Bajaj Healthcare Limited Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

BAJAJHCARE

62/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹311.15-0.55(-0.18%)

Market Closed as of Apr 2, 2026, 15:30 IST

Select time range

Pros

Technicals: Bullish SharesGuru indicator.

Profitability: Recent profitability of 8% is a good sign.

Balance Sheet: Strong Balance Sheet.

Cons

Size: It is a small market cap company and can be volatile.

Smart Money: Smart money is losing interest in the stock.

Momentum: Stock is suffering a negative price momentum. Stock is down -12% in last 30 days.

Past Returns: Underperforming stock! In past three years, the stock has provided 0.4% return compared to 9.3% by NIFTY 50.

Valuation
Market Cap	982.71 Cr
Price/Earnings (Trailing)	19.73
Price/Sales (Trailing)	1.56
EV/EBITDA	10.68
Price/Free Cashflow	149.96
MarketCap/EBT	15.99
Enterprise Value	1.19 kCr

Fundamentals
Revenue (TTM)	630.2 Cr
Rev. Growth (Yr)	30.1%
Earnings (TTM)	49.79 Cr
Earnings Growth (Yr)	33.7%

Profitability
Operating Margin	10%
EBT Margin	10%
Return on Equity	10.24%
Return on Assets	5.94%
Free Cashflow Yield	0.67%

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns
Price Change 1W	-0.90%
Price Change 1M	-12%
Price Change 6M	-35.7%
Price Change 1Y	-53.5%
3Y Cumulative Return	0.40%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-14.82 Cr
Cash Flow from Operations (TTM)	21.62 Cr
Cash Flow from Financing (TTM)	-6.38 Cr
Cash & Equivalents	11.98 Cr
Free Cash Flow (TTM)	10.08 Cr
Free Cash Flow/Share (TTM)	3.19

Balance Sheet
Total Assets	838.87 Cr
Total Liabilities	352.47 Cr
Shareholder Equity	486.39 Cr
Current Assets	472.88 Cr
Current Liabilities	269.77 Cr
Net PPE	215.31 Cr
Inventory	156.31 Cr
Goodwill	0.00

Capital Structure & Leverage
Debt Ratio	0.26
Debt/Equity	0.45
Interest Coverage	1.7
Interest/Cashflow Ops	1.88

Dividend & Shareholder Returns
Dividend/Share (TTM)	1
Dividend Yield	0.32%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	14.4%

Sharesguru Stock Score

BAJAJHCARE

62/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

Pros

Technicals: Bullish SharesGuru indicator.

Profitability: Recent profitability of 8% is a good sign.

Balance Sheet: Strong Balance Sheet.

Cons

Size: It is a small market cap company and can be volatile.

Smart Money: Smart money is losing interest in the stock.

Momentum: Stock is suffering a negative price momentum. Stock is down -12% in last 30 days.

Past Returns: Underperforming stock! In past three years, the stock has provided 0.4% return compared to 9.3% by NIFTY 50.

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Investor Care
Dividend Yield	0.32%
Dividend/Share (TTM)	1
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	15.77

Financial Health
Current Ratio	1.75
Debt/Equity	0.45

Technical Indicators
RSI (14d)	49
RSI (5d)	56.56
RSI (21d)	42.23
MACD Signal	Buy
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Hold
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Earnings Outlook

Q&A Session

Share Holdings

Understand Bajaj Healthcare ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
SAJANKUMAR RAMESHWARLAL BAJAJ	36.62%
ANIL CHAMPALAL JAIN	5.75%
NAMRATA BAJAJ	4.85%
NIHITA BAJAJ KUMAR	4.81%
BABITA SAJANKUMAR BAJAJ	4.47%
DEEPAK RAMANLAL JOSHI	2.77%
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND	1.69%
VANAJA SUNDAR IYER	1.58%
WESTSTONE MANAGEMENT CONSULTANCY PVT LTD	1.53%
PADMA ANIL JAIN	0.9%
BAJAJ HEALTH & NUTRITIONS PRIVATE LIMITED	0.71%
BANSAL PHARMA LIMITED	0.18%
SKR BAJAJ HUF	0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr

Category	BAJAJHCARE	Pharmaceuticals
PE	19.73	33.04
PS	1.56	4.56
Growth	17.9 %	8 %

Key Insights

1. BAJAJHCARE is NOT among the Top 10 largest companies in Pharmaceuticals.
2. The company holds a market share of 0.1% in Pharmaceuticals.
3. In last one year, the company has had an above average growth that other Pharmaceuticals companies.

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	14.8%	543	473	673	680	657	410
Other Income	134.1%	19	8.69	1.6	1.44	6.91	3.18
Total Income	16.6%	562	482	675	681	664	-
Cost of Materials	16.3%	307	264	520	500	463	320
Employee Expense	30.2%	57	44	48	41	35	28
Finance costs	-6.9%	28	30	23	13	8.3	6.45
Depreciation and Amortization	0%	28	28	27	18	16	-
Other expenses	18.4%	117	99	28	24	22	19
Total Expenses	13.7%	516	454	617	592	545	381
Profit Before exceptional items and Tax	66.7%	46	28	58	90	119	-
Exceptional items before tax	97.8%	0	-44.33	0	0	0	-
Total profit before tax	354.5%	46	-16.68	58	90	119	32
Current tax	-	0	0	16	22	35	9.33
Deferred tax	162.1%	3.08	-2.35	-0.53	-4.2	0.5	0.62
Total tax	162.1%	3.08	-2.35	15	18	36	9.95
Total profit (loss) for period	146%	40	-83.79	43	71	83	22
Other comp. income net of taxes	109.8%	1.37	-2.78	0.32	0.07	-0.22	-
Total Comprehensive Income	145.7%	41	-86.57	43	71	83	-
Earnings Per Share, Basic	139.2%	13.29	-30.36	15.59	25.87	30.115	8.155
Earnings Per Share, Diluted	138.6%	13.12	-30.36	15.59	25.87	30.115	8.155
Debt equity ratio	-	048	-	0	-	-	0.0153
Debt service coverage ratio	-	044	-	0	-	-	061
Interest service coverage ratio	-	0.0365	-	0	-	-	0.0637

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	8.8%	161	148	149	154	123	133
Other Income	0%	1.65	1.65	0.88	14	2.37	2.61
Total Income	8.7%	163	150	150	168	125	136
Cost of Materials	-8.1%	69	75	70	100	73	55
Employee Expense	-6.2%	16	17	14	16	15	14
Finance costs	7%	5.88	5.56	5.23	6.08	5.51	7.88
Depreciation and Amortization	2%	7.2	7.08	5.64	7.53	6.85	6.81
Other expenses	10%	34	31	29	33	26	29
Total Expenses	7.5%	144	134	135	156	114	123
Profit Before exceptional items and Tax	20%	19	16	15	12	12	12
Exceptional items before tax	-	0	0	0	0	0	0
Total profit before tax	20%	19	16	15	12	12	12
Deferred tax	-14.7%	3.14	3.51	2.35	0.13	-3.31	4.1
Total tax	-14.7%	3.14	3.51	2.35	0.13	-3.31	4.1
Total profit (loss) for period	50%	16	11	12	11	12	9.46
Other comp. income net of taxes	0%	0.19	0.19	0.19	3.45	-0.69	-0.69
Total Comprehensive Income	50%	16	11	12	15	11	8.77
Earnings Per Share, Basic	56.5%	4.96	3.53	3.74	3.54	3.65	3.36
Earnings Per Share, Diluted	56.7%	4.87	3.47	3.64	3.46	3.64	3.36
Debt equity ratio	0%	045	045	048	048	-	-
Debt service coverage ratio	1.9%	0.0243	051	055	044	-	-
Interest service coverage ratio	0.4%	0.0427	0.0387	0.0378	0.0365	-	-

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	587.5%	12	2.6	21	2.17	5.51	18
Total current financial assets	-3.5%	280	290	275	218	231	250
Inventories	-3.7%	156	162	142	144	203	209
Current tax assets	-	0	-	1.15	1.14	0	0
Total current assets	-2.5%	473	485	457	406	477	510
Property, plant and equipment	-9.3%	215	237	238	252	243	366
Capital work-in-progress	97.1%	5.83	3.45	9.69	4.8	14	22
Total non-current financial assets	182%	14	5.61	3.43	2.7	9.6	4.3
Total non-current assets	6.6%	290	272	272	284	270	392
Total assets	0.7%	839	833	804	765	838	901
Borrowings, non-current	-12.5%	57	65	31	65	57	94
Total non-current financial liabilities	-6.2%	61	65	32	66	61	94
Provisions, non-current	42%	6.65	4.98	6.12	6.14	0	2.79
Total non-current liabilities	-4.3%	67	70	38	72	61	98
Borrowings, current	4.5%	165	158	174	267	299	321
Total current financial liabilities	1.5%	268	264	279	373	397	420
Provisions, current	-284.6%	0.52	1.26	2.34	0.12	0.22	0.26
Current tax liabilities	-	0	-	-	-	13	14
Total current liabilities	-0.7%	270	272	288	376	413	436
Total liabilities	-4.1%	352	367	358	487	522	534
Equity share capital	0%	16	16	16	14	14	14
Total equity	4.3%	486	466	446	278	316	368
Total equity and liabilities	0.7%	839	833	804	765	838	901

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-34.1%	28	42	23	13	-	-
Change in inventories	-199.2%	-17.85	20	-49.52	-62.15	-	-
Depreciation	-10%	28	31	27	18	-	-
Unrealised forex losses/gains	-3838.5%	-3.86	1.13	0	0	-	-
Adjustments for interest income	-49.3%	0	0.33	0.24	0.17	-	-
Net Cashflows from Operations	-76%	26	105	-10.79	10	-	-
Income taxes paid (refund)	-70.1%	4.59	13	12	9.63	-	-
Net Cashflows From Operating Activities	-76.9%	22	92	-22.32	0.69	-	-
Proceeds from sales of PPE	-108.9%	0.11	11	0.53	0.04	-	-
Purchase of property, plant and equipment	-62.1%	12	30	94	74	-	-
Interest received	27.9%	0.51	0.32	0.24	0.17	-	-
Other inflows (outflows) of cash	-175.6%	-3.89	7.47	-0.59	-0.78	-	-
Net Cashflows From Investing Activities	-29.2%	-14.82	-11.24	-93.43	-74.8	-	-
Proceeds from issuing shares	-	150	0	0	0	-	-
Proceeds from borrowings	-	45	0	113	88	-	-
Repayments of borrowings	231.4%	170	52	-45.29	12	-	-
Payments of lease liabilities	-13%	0.13	0.23	0	0	-	-
Dividends paid	0%	2.76	2.76	4.14	1.38	-	-
Interest paid	-34.1%	28	42	23	13	-	-
Net Cashflows from Financing Activities	92.4%	-6.38	-96.6	132	62	-	-
Net change in cash and cash eq.	96.6%	0.43	-15.55	16	-12.27	-	-

Bajaj Healthcare is a pharmaceutical company that develops, manufactures, markets, and sells a variety of healthcare products. The company operates under the stock ticker BAJAJHCARE and has a market capitalization of Rs. 1,816.4 Crores.

The company specializes in multiple areas, offering active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms for the pharmaceutical, nutraceutical, and food industries both in India and internationally.

Bajaj Healthcare provides APIs across various therapeutic categories, including:

Antidiabetic
Antibiotic
Antiviral
Antifungal
Antihypertensive
Antiallergic
Nutritional supplements, and many more.

Additionally, the company produces intermediates such as guanine and theophylline derivatives, and a range of other specialized compounds. It also offers formulations in diverse formats including tablets, capsules, sachets, and vials.

Established in 1993 and based in Thane, India, Bajaj Healthcare reported a trailing twelve months revenue of Rs. 534.3 Crores. The company has a dividend yield of 0.18%, contributing Rs. 1 dividend per share over the last year.

However, over the past three years, Bajaj Healthcare experienced a revenue decline of 16.4% and reported a 14.4% dilution of shareholder holdings. This reflects some challenges faced by the company in maintaining its financial dynamics and growth.

Industry Group:Pharmaceuticals & Biotechnology

Employees:1,049

Website:www.bajajhealth.com

Important Disclosure & Data Context

This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.

Earnings Outlook

Q&A Session

Share Holdings

Understand Bajaj Healthcare ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

Shareholder Name	Holding %
SAJANKUMAR RAMESHWARLAL BAJAJ	36.62%
ANIL CHAMPALAL JAIN	5.75%
NAMRATA BAJAJ	4.85%
NIHITA BAJAJ KUMAR	4.81%
BABITA SAJANKUMAR BAJAJ	4.47%
DEEPAK RAMANLAL JOSHI	2.77%
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND	1.69%
VANAJA SUNDAR IYER	1.58%
WESTSTONE MANAGEMENT CONSULTANCY PVT LTD	1.53%
PADMA ANIL JAIN	0.9%
BAJAJ HEALTH & NUTRITIONS PRIVATE LIMITED	0.71%
BANSAL PHARMA LIMITED	0.18%
SKR BAJAJ HUF	0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr

Category	BAJAJHCARE	Pharmaceuticals
PE	19.73	33.04
PS	1.56	4.56
Growth	17.9 %	8 %

Key Insights

1. BAJAJHCARE is NOT among the Top 10 largest companies in Pharmaceuticals.
2. The company holds a market share of 0.1% in Pharmaceuticals.
3. In last one year, the company has had an above average growth that other Pharmaceuticals companies.

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	14.8%	543	473	673	680	657	410
Other Income	134.1%	19	8.69	1.6	1.44	6.91	3.18
Total Income	16.6%	562	482	675	681	664	-
Cost of Materials	16.3%	307	264	520	500	463	320
Employee Expense	30.2%	57	44	48	41	35	28
Finance costs	-6.9%	28	30	23	13	8.3	6.45
Depreciation and Amortization	0%	28	28	27	18	16	-
Other expenses	18.4%	117	99	28	24	22	19
Total Expenses	13.7%	516	454	617	592	545	381
Profit Before exceptional items and Tax	66.7%	46	28	58	90	119	-
Exceptional items before tax	97.8%	0	-44.33	0	0	0	-
Total profit before tax	354.5%	46	-16.68	58	90	119	32
Current tax	-	0	0	16	22	35	9.33
Deferred tax	162.1%	3.08	-2.35	-0.53	-4.2	0.5	0.62
Total tax	162.1%	3.08	-2.35	15	18	36	9.95
Total profit (loss) for period	146%	40	-83.79	43	71	83	22
Other comp. income net of taxes	109.8%	1.37	-2.78	0.32	0.07	-0.22	-
Total Comprehensive Income	145.7%	41	-86.57	43	71	83	-
Earnings Per Share, Basic	139.2%	13.29	-30.36	15.59	25.87	30.115	8.155
Earnings Per Share, Diluted	138.6%	13.12	-30.36	15.59	25.87	30.115	8.155
Debt equity ratio	-	048	-	0	-	-	0.0153
Debt service coverage ratio	-	044	-	0	-	-	061
Interest service coverage ratio	-	0.0365	-	0	-	-	0.0637

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	8.8%	161	148	149	154	123	133
Other Income	0%	1.65	1.65	0.88	14	2.37	2.61
Total Income	8.7%	163	150	150	168	125	136
Cost of Materials	-8.1%	69	75	70	100	73	55
Employee Expense	-6.2%	16	17	14	16	15	14
Finance costs	7%	5.88	5.56	5.23	6.08	5.51	7.88
Depreciation and Amortization	2%	7.2	7.08	5.64	7.53	6.85	6.81
Other expenses	10%	34	31	29	33	26	29
Total Expenses	7.5%	144	134	135	156	114	123
Profit Before exceptional items and Tax	20%	19	16	15	12	12	12
Exceptional items before tax	-	0	0	0	0	0	0
Total profit before tax	20%	19	16	15	12	12	12
Deferred tax	-14.7%	3.14	3.51	2.35	0.13	-3.31	4.1
Total tax	-14.7%	3.14	3.51	2.35	0.13	-3.31	4.1
Total profit (loss) for period	50%	16	11	12	11	12	9.46
Other comp. income net of taxes	0%	0.19	0.19	0.19	3.45	-0.69	-0.69
Total Comprehensive Income	50%	16	11	12	15	11	8.77
Earnings Per Share, Basic	56.5%	4.96	3.53	3.74	3.54	3.65	3.36
Earnings Per Share, Diluted	56.7%	4.87	3.47	3.64	3.46	3.64	3.36
Debt equity ratio	0%	045	045	048	048	-	-
Debt service coverage ratio	1.9%	0.0243	051	055	044	-	-
Interest service coverage ratio	0.4%	0.0427	0.0387	0.0378	0.0365	-	-

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	587.5%	12	2.6	21	2.17	5.51	18
Total current financial assets	-3.5%	280	290	275	218	231	250
Inventories	-3.7%	156	162	142	144	203	209
Current tax assets	-	0	-	1.15	1.14	0	0
Total current assets	-2.5%	473	485	457	406	477	510
Property, plant and equipment	-9.3%	215	237	238	252	243	366
Capital work-in-progress	97.1%	5.83	3.45	9.69	4.8	14	22
Total non-current financial assets	182%	14	5.61	3.43	2.7	9.6	4.3
Total non-current assets	6.6%	290	272	272	284	270	392
Total assets	0.7%	839	833	804	765	838	901
Borrowings, non-current	-12.5%	57	65	31	65	57	94
Total non-current financial liabilities	-6.2%	61	65	32	66	61	94
Provisions, non-current	42%	6.65	4.98	6.12	6.14	0	2.79
Total non-current liabilities	-4.3%	67	70	38	72	61	98
Borrowings, current	4.5%	165	158	174	267	299	321
Total current financial liabilities	1.5%	268	264	279	373	397	420
Provisions, current	-284.6%	0.52	1.26	2.34	0.12	0.22	0.26
Current tax liabilities	-	0	-	-	-	13	14
Total current liabilities	-0.7%	270	272	288	376	413	436
Total liabilities	-4.1%	352	367	358	487	522	534
Equity share capital	0%	16	16	16	14	14	14
Total equity	4.3%	486	466	446	278	316	368
Total equity and liabilities	0.7%	839	833	804	765	838	901

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-34.1%	28	42	23	13	-	-
Change in inventories	-199.2%	-17.85	20	-49.52	-62.15	-	-
Depreciation	-10%	28	31	27	18	-	-
Unrealised forex losses/gains	-3838.5%	-3.86	1.13	0	0	-	-
Adjustments for interest income	-49.3%	0	0.33	0.24	0.17	-	-
Net Cashflows from Operations	-76%	26	105	-10.79	10	-	-
Income taxes paid (refund)	-70.1%	4.59	13	12	9.63	-	-
Net Cashflows From Operating Activities	-76.9%	22	92	-22.32	0.69	-	-
Proceeds from sales of PPE	-108.9%	0.11	11	0.53	0.04	-	-
Purchase of property, plant and equipment	-62.1%	12	30	94	74	-	-
Interest received	27.9%	0.51	0.32	0.24	0.17	-	-
Other inflows (outflows) of cash	-175.6%	-3.89	7.47	-0.59	-0.78	-	-
Net Cashflows From Investing Activities	-29.2%	-14.82	-11.24	-93.43	-74.8	-	-
Proceeds from issuing shares	-	150	0	0	0	-	-
Proceeds from borrowings	-	45	0	113	88	-	-
Repayments of borrowings	231.4%	170	52	-45.29	12	-	-
Payments of lease liabilities	-13%	0.13	0.23	0	0	-	-
Dividends paid	0%	2.76	2.76	4.14	1.38	-	-
Interest paid	-34.1%	28	42	23	13	-	-
Net Cashflows from Financing Activities	92.4%	-6.38	-96.6	132	62	-	-
Net change in cash and cash eq.	96.6%	0.43	-15.55	16	-12.27	-	-

Bajaj Healthcare provides APIs across various therapeutic categories, including:

Antidiabetic
Antibiotic
Antiviral
Antifungal
Antihypertensive
Antiallergic
Nutritional supplements, and many more.

Industry Group:Pharmaceuticals & Biotechnology

Employees:1,049

Website:www.bajajhealth.com

BAJAJHCARE - Bajaj Healthcare Limited Share Price

BAJAJHCARE

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

BAJAJHCARE

BAJAJHCARE - Bajaj Healthcare Limited Share Price

BAJAJHCARE

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

BAJAJHCARE

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Bajaj Healthcare Limited do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Bajaj Healthcare Limited do?

Important Disclosure & Data Context